cancer clinical trials in detroit, MI
Wayne State University
Detroit, Michigan 48202 Renal Cell Carcinoma
|
Josephine Ford Cancer Center at Henry Ford Hospital
Detroit, Michigan 48202 Lymphoma
|
Pfizer Investigational Site
Detroit, Michigan 48201 Non-Small Cell Lung Cancer (NSCLC)
|
Karmanos Cancer Institute
Detroit, Michigan 48201 Metastatic Pancreatic Adenocarcinoma
|
Karmanos Cancer Institute
Detroit, Michigan 48201 Non Small Cell Lung Cancer
|
Wayne State University/Karmanos Cancer Institute Study Coordinator
Detroit, Michigan 48201 Advanced Solid Tumors,, Selected Solid Tumors
|
Pfizer Investigational Site
Detroit, Michigan 48201 Acute Lymphocytic Leukemia
|
Wayne State University
Detroit, Michigan 48202 Extensive Stage Small Cell Lung Cancer, Recurrent Borderline Ovarian Surface Epithelial-stromal Tumor, Recurrent Breast Cancer, Recurrent Melanoma, Recurrent Non-small Cell Lung Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Ovarian Germ Cell Tumor, Recurrent Small Cell Lung Cancer, Stage IV Borderline Ovarian Surface Epithelial-stromal Tumor, Stage IV Breast Cancer, Stage IV Melanoma, Stage IV Non-small Cell Lung Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Ovarian Germ Cell Tumor, Unspecified Adult Solid Tumor, Protocol Specific
|
Barbara Ann Karmanos Cancer Institute
Trial Locations Barbara Ann Karmanos Cancer Institute Josephine Ford Cancer Center at Henry Ford Hospital Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
|
Henry Ford Hospital
Detroit, Michigan 48202 Urinary Incontinence
|
Barbara Ann Karmanos Cancer Institute
Detroit, Michigan 48201 Anxiety Disorder, Fallopian Tube Cancer, Fatigue, Nausea and Vomiting, Neurotoxicity, Ovarian Cancer, Primary Peritoneal Cavity Cancer
|
Henry Ford Health System
Detroit, Michigan 48202 Head and Neck Cancer
|
Josephine Ford Cancer Center at Henry Ford Hospital
Detroit, Michigan 48202 Arthralgia, Breast Cancer, Pain
|
Children's Hospital of Michigan
Detroit, Michigan 48201 Acute Myeloid Leukemia
|
Wayne State University
Detroit, Michigan 48202 Adenocarcinoma of the Lung, Adenosquamous Cell Lung Cancer, Bronchoalveolar Cell Lung Cancer, Large Cell Lung Cancer, Squamous Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer
|
Karmanos Cancer Center
Detroit, Michigan 48201 Oral Mucositis
|
Henry Ford Hospital
Detroit, Michigan 48202 Hepatitis C, Renal Cell Carcinoma, Colorectal Cancer
|
Wayne State University
Trial Locations Wayne State University Saint John Hospital and Medical Center B-cell Adult Acute Lymphoblastic Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia, Cognitive/Functional Effects, Neurotoxicity, Pain, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, Therapy-related Toxicity, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
|
Barbara Ann Karmanos Cancer Institute
Detroit, Michigan 48201 Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Chronic Myelomonocytic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Contiguous Stage II Adult Burkitt Lymphoma, Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma, Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Stage II Adult Immunoblastic Large Cell Lymphoma, Contiguous Stage II Adult Lymphoblastic Lymphoma, Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular Lymphoma, Contiguous Stage II Grade 3 Follicular Lymphoma, Contiguous Stage II Mantle Cell Lymphoma, Cutaneous B-cell Non-Hodgkin Lymphoma, de Novo Myelodysplastic Syndromes, Hepatosplenic T-cell Lymphoma, Intraocular Lymphoma, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Nodal Marginal Zone B-cell Lymphoma, Noncontiguous Stage II Adult Burkitt Lymphoma, Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Grade 1 Follicular Lymphoma, Noncontiguous Stage II Grade 2 Follicular Lymphoma, Noncontiguous Stage II Grade 3 Follicular Lymphoma, Noncontiguous Stage II Mantle Cell Lymphoma, Peripheral T-cell Lymphoma, Post-transplant Lymphoproliferative Disorder, Previously Treated Myelodysplastic Syndromes, Primary Myelofibrosis, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia, Refractory Hairy Cell Leukemia, Small Intestine Lymphoma, Splenic Marginal Zone Lymphoma, Stage I Adult Burkitt Lymphoma, Stage I Adult Diffuse Large Cell Lymphoma, Stage I Adult Diffuse Mixed Cell Lymphoma, Stage I Adult Diffuse Small Cleaved Cell Lymphoma, Stage I Adult Hodgkin Lymphoma, Stage I Adult Immunoblastic Large Cell Lymphoma, Stage I Adult Lymphoblastic Lymphoma, Stage I Adult T-cell Leukemia/Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Grade 1 Follicular Lymphoma, Stage I Grade 2 Follicular Lymphoma, Stage I Grade 3 Follicular Lymphoma, Stage I Mantle Cell Lymphoma, Stage I Marginal Zone Lymphoma, Stage I Multiple Myeloma, Stage I Mycosis Fungoides/Sezary Syndrome, Stage I Small Lymphocytic Lymphoma, Stage II Adult Hodgkin Lymphoma, Stage II Adult T-cell Leukemia/Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Multiple Myeloma, Stage II Mycosis Fungoides/Sezary Syndrome, Stage III Adult Burkitt Lymphoma, Stage III Adult Diffuse Large Cell Lymphoma, Stage III Adult Diffuse Mixed Cell Lymphoma, Stage III Adult Diffuse Small Cleaved Cell Lymphoma, Stage III Adult Hodgkin Lymphoma, Stage III Adult Immunoblastic Large Cell Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Adult T-cell Leukemia/Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma, Stage III Mantle Cell Lymphoma, Stage III Marginal Zone Lymphoma, Stage III Multiple Myeloma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage III Small Lymphocytic Lymphoma, Stage IV Adult Burkitt Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Mixed Cell Lymphoma, Stage IV Adult Diffuse Small Cleaved Cell Lymphoma, Stage IV Adult Hodgkin Lymphoma, Stage IV Adult Immunoblastic Large Cell Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Adult T-cell Leukemia/Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma, Stage IV Mantle Cell Lymphoma, Stage IV Marginal Zone Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, Stage IV Small Lymphocytic Lymphoma, T-cell Large Granular Lymphocyte Leukemia, Testicular Lymphoma, Waldenstrom Macroglobulinemia
|
Barbara Ann Karmanos Cancer Institute
Detroit, Michigan 48201 Metastatic Renal Cell Carcinoma, Metastatic Melanoma
|
Barbara Ann Karmanos Cancer Institute
Detroit, Michigan 48201 Lymphoma, Neurotoxicity, Therapy-related Toxicity
|
Pfizer Investigational Site
Detroit, Michigan 48201 Endometrial Neoplasms
|
Barbara Ann Karmanos Cancer Institute
Detroit, Michigan 48201 Colorectal Cancer, Cancer of Pancreas, Pancreatic Neoplasm, Malignant Neoplasm of Large Intestine, Malignant Tumor of Colon, Colon Carcinoma, Cancer of Colon, Pancreatic Cancer
|
Wayne State University/Children's Hospital of Michigan
Detroit, Michigan 48201 Sturge-Weber Syndrome
|
Karmanos Cancer Institute
Detroit, Michigan 48201 Prostate Cancer
|
Karmanos Cancer Institute
Detroit, Michigan 48201 Acute Lymphoblastic Leukemia (ALL)
|
Karmanos Cancer Institute
Detroit, Michigan 48201 Urologic Neoplasms, Metastatic Bladder Cancer, Urinary Tract Neoplasms
|
Barbara Ann Karmanos Cancer Institute
Detroit, Michigan 48201 Multiple Myeloma
|
Children's Hospital of Michigan
Trial Locations Children's Hospital of Michigan Local Institution Leukemia, Pediatric
|
Pfizer Investigational Site
Detroit, Michigan 48201 Non Small Cell Lung Cancer (NSCLC)
|
Barbara Ann Karmanos Cancer Institute
Detroit, Michigan 48201 Acute Lymphoblastic Leukemia
|
Saint John Hospital and Medical Center
Detroit, Michigan 48236 Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Hepatosplenic T-cell Lymphoma, Peripheral T-cell Lymphoma, Recurrent Adult Non-Hodgkin Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma
|
Barbara Ann Karmanos Cancer Institute
Detroit, Michigan 48201 Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate Cancer
|
Saint John Hospital and Medical Center
Detroit, Michigan 48236 Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer
|
Henry Ford Hospital
Detroit, Michigan 48202 Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Anaplastic Oligoastrocytoma
|
Site Reference ID/Investigator# 57555
Detroit, Michigan 48201 Advanced Solid Tumors
|
Local Institution
Detroit, Michigan Multiple Myeloma
|
Karmanos Cancer Institute
Detroit, Michigan 48201 Relapsed or Refractory Solid Tumors
|
Henry Ford Hospital
Detroit, Michigan 48202 Brain and Central Nervous System Tumors
|
Henry Ford Hospital
Detroit, Michigan 48202 Breast Cancer, Brain Metastases
|
Karmanos Cancer Institute
Detroit, Michigan 48201 Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer
|
Henry Ford Health System
Trial Locations Henry Ford Health System Karmanos Cancer Institute Relapsed Peripheral T-Cell Lymphoma, Refractory Peripheral T-Cell Lymphoma
|
Henry Ford Health Systems
Trial Locations Henry Ford Health Systems Detroit Medical Center ST Segment Elevation Myocardial Infarction
|
Josephine Ford Cancer Center at Henry Ford Hospital
Detroit, Michigan 48202 Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer, Gastric Cancer
|
Wayne State University
Detroit, Michigan 48202 Childhood Hepatocellular Carcinoma, Papillary Thyroid Cancer, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Childhood Liver Cancer, Recurrent Childhood Rhabdomyosarcoma, Recurrent Thyroid Cancer, Recurrent Wilms Tumor and Other Childhood Kidney Tumors
|
Barbara Ann Karmanos Cancer Institute
Detroit, Michigan 48201 Leukemia
|
Barbara Ann Karmanos Cancer Institute
Detroit, Michigan 48201 Gastrointestinal Cancer, Nausea Post Chemotherapy
|
Henry Ford Health System
Detroit, Michigan 48202 Metastatic Colorectal Cancer, Colorectal Cancer
|
Morang Chester Clinic
Trial Locations Morang Chester Clinic David Williams, MD Andrew Thomas, MD Rice Lanzilote & Egan Colorectal Cancer
|
Karmanos Cancer Institute
Detroit, Michigan 48201 Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute
|
Karmanos Cancer Institute
Detroit, Michigan 48201 Anemia, Sickle Cell
|
Wayne State University
Detroit, Michigan 48202 Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes, Refractory Anemia With Excess Blasts, Secondary Myelodysplastic Syndromes
|
1200.125.10028 Boehringer Ingelheim Investigational Site
Detroit, Michigan Carcinoma, Non-Small-Cell Lung
|
Henry Ford Hospital
Detroit, Michigan 48202 Well-differentiated Pancreatic Neuroendocrine Tumor
|